These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8106162)

  • 1. How well are the cardiovascular risk profiles modulated by current beta blockers in hypertension?
    Hayduk K
    Cardiology; 1993; 82 Suppl 3():3-7. PubMed ID: 8106162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol in hypertension.
    Raftery EB
    Cardiology; 1993; 82 Suppl 3():40-4. PubMed ID: 8106164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors in hypertension: rationale and design of studies to investigate the effects of controlled-release carvedilol on regression of left ventricular hypertrophy and lipid profile.
    Bakris GL; Tarka EA; Waterhouse B; Goulding MR; Madan A; Anderson KM; St John Sutton M; Miller AB; Reichek N
    Am J Cardiol; 2006 Oct; 98(7A):46L-52L. PubMed ID: 17023232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers for hypertension: are they going out of style?
    Che Q; Schreiber MJ; Rafey MA
    Cleve Clin J Med; 2009 Sep; 76(9):533-42. PubMed ID: 19726558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilating versus first-generation β-blockers for cardiovascular protection.
    Fares H; Lavie CJ; Ventura HO
    Postgrad Med; 2012 Mar; 124(2):7-15. PubMed ID: 22437211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The foundation role of beta blockers across the cardiovascular disease spectrum: a year 2009 update.
    Black HR; Greenberg BH; Weber MA
    Am J Med; 2010 Nov; 123(11):S2. PubMed ID: 21035578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
    Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-adrenoblockers for the correction of arterial hypertension in postmenopausal women].
    Latfullin IA; Ishmurzin GP; Gaĭfullina RF; Akhmerova RI; Kim ZF; Podol'skaia AA
    Klin Med (Mosk); 2010; 88(2):68-71. PubMed ID: 21105477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiprolol in hypertension.
    Taylor SH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1426-34. PubMed ID: 2903654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol--clinical experience in arrhythmias.
    Storstein L
    Cardiology; 1993; 82 Suppl 3():29-33. PubMed ID: 8106161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive treatment with a dual-acting beta-blocker in the elderly.
    Lessem JN; Weber MA
    J Hypertens Suppl; 1993 Jun; 11(4):S29-36. PubMed ID: 8104239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of left ventricular hypertrophy--are there differences between antihypertensive agents?
    Dahlöf B
    Cardiology; 1992; 81(4-5):307-15. PubMed ID: 1363788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic profile of carvedilol.
    van Zwieten PA
    Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
    Krauser DG; Devereux RB
    Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression from hypertension to heart failure. Mechanisms and management.
    Cleland JG
    Cardiology; 1999; 92 Suppl 1():10-9; discussion 20-1. PubMed ID: 10652967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus.
    Fardoun RZ
    Pharmacotherapy; 2006 Oct; 26(10):1491-500. PubMed ID: 16999659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.